Prosecution Insights
Last updated: August 15, 2026

University of Maryland, Baltimore

22 pending office actions • 14 art units • 21 examiners • 0 of 22 (0%) have an AI response strategy ready • 25 patents granted in the last 365 days

Portfolio Summary

22
Total Pending OAs
14
Non-Final OAs
8
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
4
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (4)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

11
Hard (50%)
11
Medium (50%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other3 (14%)
§103 only8 (36%)
§102 only2 (9%)
Double-patenting + other1 (5%)
Multi-statute (no §101)8 (36%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

17
Life Sciences
77% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
9% of docket
3
Business / Other
14% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

220 h
Manual time on pending OAs
44 h
Time saved (low, 20%)
77 h
Time saved (mid, 35%)
1.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MINCHELLA, KAITLYN L 2 26.9% +22.1%
SHI, KATHERINE MENGLIN 1 78.4% +21.7%
VARADARAJ, ARCHANA 1 100.0% +0.0%
DEAK, LESLIE R 1 75.4% +17.5%
KRASNOW, NICHOLAS R 1 66.5% +12.5%
AMIN, ALPA NILESH 1 50.0% +0.0%
NGUYEN, HIEP VAN 1 55.2% +29.5%
O DELL, DAVID K 1 57.7% +36.0%
GILL, RACHEL B 1 65.4% +28.0%
BARRERA, IMMACULADA 1 34.6% +77.3%

Hard Cases (11)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17970448 Magnetic-Responsive Photosensitizer Nanoplatform and Uses Thereof NOTTINGHAM, KYLE GREGORY 92d overdue
15028253 METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES MINCHELLA, KAITLYN L 14d
15489658 METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES MINCHELLA, KAITLYN L 21d
19070050 HEART VALVE REPAIR USING SUTURE KNOTS SHI, KATHERINE MENGLIN
18761250 DIAGNOSIS AND TREATMENT OF VASODILATORY SHOCK VARADARAJ, ARCHANA
18569156 THREE-DIMENSIONAL CELL-LADEN BIOINK SCAFFOLDS AND METHODS OF MAKING THE SAME UNDER CRYOGENIC CONDITIONS FOR TISSUE ENGINEERING KRASNOW, NICHOLAS R
18271884 METHOD AND APPARATUS FOR AUTOMATING MODELS FOR INDIVIDUALIZED ADMINISTRATION OF MEDICAMENTS NGUYEN, HIEP VAN
18265191 BROAD SPECTRUM ANTIVIRAL COMPOUNDS TARGETING THE SKI COMPLEX O DELL, DAVID K

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
15028253 METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES MINCHELLA, KAITLYN L 14d
15489658 METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES MINCHELLA, KAITLYN L 21d
19070050 HEART VALVE REPAIR USING SUTURE KNOTS SHI, KATHERINE MENGLIN
18739456 SELF-SEALING CANNULA DEAK, LESLIE R
18569156 THREE-DIMENSIONAL CELL-LADEN BIOINK SCAFFOLDS AND METHODS OF MAKING THE SAME UNDER CRYOGENIC CONDITIONS FOR TISSUE ENGINEERING KRASNOW, NICHOLAS R
18271884 METHOD AND APPARATUS FOR AUTOMATING MODELS FOR INDIVIDUALIZED ADMINISTRATION OF MEDICAMENTS NGUYEN, HIEP VAN
18265191 BROAD SPECTRUM ANTIVIRAL COMPOUNDS TARGETING THE SKI COMPLEX O DELL, DAVID K
18298540 RAPID AND LOW-COST SAMPLING FOR DETECTION OF AIRBORNE SARS-COV-2 IN DEHUMIDIFIER CONDENSATE GILL, RACHEL B

Top Art Units

Art UnitApps
1621 2
1671 2
1628 2
1656 2
1685 2
1744 1
1655 1
3686 1
1625 1
1794 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19070050 HEART VALVE REPAIR USING SUTURE KNOTS SHI, KATHERINE MENGLIN §103§112 Non-Final OA Pending Mar 04, 2025
18761250 DIAGNOSIS AND TREATMENT OF VASODILATORY SHOCK VARADARAJ, ARCHANA §101§102 Non-Final OA Pending Jul 01, 2024
18739456 SELF-SEALING CANNULA DEAK, LESLIE R §102DP Non-Final OA Pending Jun 11, 2024
18569156 THREE-DIMENSIONAL CELL-LADEN BIOINK SCAFFOLDS AND METHODS OF MAKING THE SAME UNDER CRYOGENIC CONDITIONS FOR TISSUE ENGINEERING KRASNOW, NICHOLAS R 1744 §103§112 Non-Final OA Pending Dec 11, 2023
18261203 METHODS AND PLATFORMS FOR PROMOTING ANTIGEN-SPECIFIC TOLERANCE IN THE TREATMENT OF TYPE 1 DIABETES AND GRAFT REJECTION AND COMPOSITIONS RELATING THERETO AMIN, ALPA NILESH 1655 §102 Non-Final OA 40d Pending Jul 12, 2023
18271884 METHOD AND APPARATUS FOR AUTOMATING MODELS FOR INDIVIDUALIZED ADMINISTRATION OF MEDICAMENTS NGUYEN, HIEP VAN 3686 §101§103 Non-Final OA Pending Jul 12, 2023
18265191 BROAD SPECTRUM ANTIVIRAL COMPOUNDS TARGETING THE SKI COMPLEX O DELL, DAVID K 1621 §102§112Other Final Rejection Pending Jun 02, 2023
18298540 RAPID AND LOW-COST SAMPLING FOR DETECTION OF AIRBORNE SARS-COV-2 IN DEHUMIDIFIER CONDENSATE GILL, RACHEL B 1671 §103§112 Non-Final OA Pending Apr 11, 2023
18026199 SHARK-DERIVED BINDING MOLECULES FOR SARS-COV-2 CORONAVIRUS AND USES THEREOF BARRERA, IMMACULADA 1671 §101§112 Non-Final OA Pending Mar 14, 2023
18000471 GEL FOR USE IN GASTROINTESTINAL ENDOSCOPY AND ENDODERMAL, EPIDERMAL, AND OTHER MUCOSAL USES BARSKY, JARED 1628 §103 Final Rejection Pending Dec 01, 2022
18048731 DUAL HDAC6/PROTEASOME INHIBITORS, AND METHODS OF USE THEREOF MCANANY, JOHN D 1625 §103 Non-Final OA Pending Oct 21, 2022
17970448 Magnetic-Responsive Photosensitizer Nanoplatform and Uses Thereof NOTTINGHAM, KYLE GREGORY 1621 §102§103§112 Final Rejection 92d overdue Pending Oct 20, 2022
17956454 Electrochemical Method for Detecting Clozapine OSMAN, SOMMER YOUSEF 1794 §103 Non-Final OA Pending Sep 29, 2022
17774215 METHODS FOR DISTINGUISHING THE STAGES OF BACTERIAL VAGINOSIS MCKNIGHT, CIARA A 1656 §103 Non-Final OA 19d Pending May 04, 2022
17767783 COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACIDS TO CELLS PURDY, KYLE A 1611 §103 Non-Final OA 27d Pending Apr 08, 2022
17616586 BROAD SPECTRUM ANTIVIRAL COMPOUNDS TARGETING THE SKI COMPLEX CHENG, KAREN 1623 §102 Final Rejection Pending Dec 03, 2021
17465113 TRANS-ESOPHAGEAL AORTIC FLOW RATE CONTROL LABRANCHE, BROOKE N 3771 §103 Non-Final OA 70d Pending Sep 02, 2021
17415344 ASPARAGINASE-INDUCED GLUTAMINE DEPLETION COMBINED WITH BCL-2 INHIBITION FOR TREATMENT OF HEMATOLOGIC AND SOLID CANCERS SPANGLER, JOSEPH RANKIN 1656 §103 Final Rejection Pending Jun 17, 2021
17056845 METHODS OF INHIBITING PROINFLAMMATORY NEUROIMMUNE SIGNALING AND TREATING INFLAMMATORY DISORDERS COPPINS, JANET L 1628 §103§112 Final Rejection Pending Nov 19, 2020
16813263 Methods of Generating Mature Human Muscle Fibers POPA, ILEANA 1633 §103Other Non-Final OA 89d overdue Pending Mar 09, 2020
15489658 METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES MINCHELLA, KAITLYN L 1685 §103§112 Final Rejection 21d Pending Apr 17, 2017
15028253 METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES MINCHELLA, KAITLYN L 1685 §102§112Other Final Rejection 14d Pending Apr 08, 2016

Managing University of Maryland, Baltimore's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month